article thumbnail

How GPCR-targeting therapies are advancing the fight against inflammatory disease

Drug Target Review

All these features make GPCRs central to regulating many vital biological processes in the body, including immune responses and inflammation, and thus especially attractive for therapeutic intervention. Stephan holds a PhD in medical chemistry from University of Strasbourg in France.

Disease 59
article thumbnail

Addressing increasingly resistant drugs by infectious agents

Drug Target Review

2018): Silent Information Regulator 2 from Trypanosoma cruzi is a potential target to infection control, IntechOpen. 2011): State of the Art in African Trypanosome Drug Discovery, Current topic of medical chemistry. 12(11): e0006980. Nilmar, S. and Anabela, C. doi.org/10.5772/intechopen.770301 770301 Mark, C. Michael, A.

Drugs 111